Tech Company Financing Transactions
CoLucid Pharmaceuticals Funding Round
CoLucid Pharmaceuticals, based in Cambridge, received $8.3 million from Domain Associates, MPM Capital and Pappas Ventures.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$8,250,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
P.O. Box 425227
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
CoLucid Pharma is a biotech company focusing on therapies for CNS disorders, Migraine, sleep/wake disorders, chronic pain, Alzheimers, and psychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Mathers
Chief Financial Officer
Matthew Dallas
VP - Bus. Development
Linda Hogan
VP - General Counsel
Daniel Boeglin
VP - R & D
Nadia Rupniak
VP - Regulatory Affairs
Bernice Kuca
Browse more venture capital transactions:
Prev: 6/30/2007: Zipit Wireless venture capital transaction
Next: 6/30/2007: Zenprise venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs